In a desperatebid to save itself, Insys's new managers are trying to sell off itsmain pain drug to a corporate buyer to raise money. (Image: Shutterstock)
Sitting in a Boston courtroom in a dark, pinstriped suit, theformer top sales executive at Insys Therapeutics Inc., Alex Burlakoff,listened as federal prosecutors read out crimes he and the companyhad allegedly committed.
Insys had bribed doctors and their employees withpayments for sham medical events that often turned out to beparties. Physicians who didn't write prescriptions for the company's powerfulopioid were cut off from the company's money. There were lavishdinners, strip-club visits and gun-range outings, all of which ledto booming sales of one of the world's most powerful — anddangerous — pain drugs.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
